Zenith Drugs (NSE:ZENITHDRUG) Construction In Progress: ₹98 Mil (As of Mar. 2026)


NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
45 GF Score
Price ₹53.90
! 6 Warning Signs
View Full Analysis

What is Zenith Drugs Construction In Progress?

Zenith Drugs NSE:ZENITHDRUG +5.38% 45 Construction In Progress is ₹98 Mil as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 45/100. The stock has 6 warning signs investors should review.

Zenith Drugs's quarterly construction in progress increased from Mar. 2025 (₹31 Mil) to Sep. 2025 (₹45 Mil) and increased from Sep. 2025 (₹45 Mil) to Mar. 2026 (₹98 Mil).

Zenith Drugs's annual construction in progress declined from Mar. 2024 (₹79 Mil) to Mar. 2025 (₹31 Mil) but then increased from Mar. 2025 (₹31 Mil) to Mar. 2026 (₹98 Mil).

Zenith Drugs Construction In Progress Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Construction In Progress Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial 26.62 0.00 79.27 31.02 98.18

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only 79.27 0.00 31.02 44.99 98.18
NSE:ZENITHDRUG
45GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹98 Mil mean?
Zenith Drugs (NSE:ZENITHDRUG) has a Construction In Progress of ₹98 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' Construction In Progress too high?
Zenith Drugs' current Construction In Progress is ₹98 Mil. Overall, Zenith Drugs has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Construction In Progress compare to ZTS and UTHR?
Zenith Drugs' Construction In Progress of ₹98 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current Construction In Progress is ₹98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Construction In Progress of ₹98 Mil. The current Construction In Progress is ₹98 Mil. Zenith Drugs' overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Construction In Progress is ₹98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
45GF Score

Get the complete analysis for NSE:ZENITHDRUG

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹53.90
Price